Location History:
- Fort Dodge, IA (US) (2011)
- Mattawan, MI (US) (2012)
Company Filing History:
Years Active: 2011-2012
Title: **Inventor Muhammad Ayub Khan: Innovating Vaccine Technologies**
Introduction
Muhammad Ayub Khan, an innovative inventor based in Mattawan, MI, has made significant contributions to the field of biotechnology. With a total of two patents, Khan's work primarily focuses on live, attenuated bacteria and vaccines, showcasing his dedication to advancing health technologies.
Latest Patents
Khan's latest patents revolve around the development of live, attenuated bacteria that exhibit reduced expression of a protein identified as MGA_0621. These ingenious inventions provide innovative solutions in the realm of vaccine development. In one embodiment, the attenuated bacteria not only show diminished expression of MGA_0621 but may also exhibit reduced levels of other key proteins, including pyruvate dehydrogenase, phosphopyruvate hydratase, and ribosomal protein L35, compared to wild-type bacteria. The patents also encompass vaccines and vaccination methods utilizing these live, attenuated bacteria, along with the methods for their creation. An exemplary strain, designated MGx+47, has demonstrated significantly reduced expression of MGA_0621 and has proven to be both safe and effective when administered as a vaccine against infections in chickens.
Career Highlights
Khan is currently working at Wyeth, a prominent biopharmaceutical company well-regarded for its commitment to developing innovative vaccines and therapeutics. His remarkable expertise in the field has positioned him as a vital contributor to his organization’s mission of advancing public health through scientifically backed solutions.
Collaborations
In his career, Muhammad Ayub Khan has collaborated with talented professionals, including his coworker Mahesh Kumar. This partnership not only enhances the innovative capacity of Wyeth but also facilitates the exchange of ideas that stimulate impactful advancements in vaccine development.
Conclusion
In summary, Muhammad Ayub Khan stands out as a trailblazer in the biotechnology sector with a strong focus on live attenuated bacteria and vaccine innovation. His significant contributions, reflected through his patents, showcase his commitment to improving health outcomes, solidifying his status as a notable inventor in the field.